Product Name:

NebuPeptide™ Lanreotide (Peptide Reference)

Catalog Number:

NBS-233769

Description:

NebuPeptide™ Lanreotide (Peptide Reference)(CAT#NBS-233769) is synthesized in accordance with the Lanreotide sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Goserelin reference peptide ranging from milligrams to kilograms.

Peptide Name:

Lanreotide

Background:

Lanreotide (Ipstyl; Somatulin; BIM-23014; Lanreotide Autogel), a synthetic somatostatin analogue, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2. Lanreotide suppresses GH/IGF-I hypersecretion in acromegaly patients and used to manage neuroendocrine tumours.

Alias:

Somatulin; Somatuline; Lanreotide; Ipstyl; BIM23014; Lanreotide Autogel

CAS Number:

108736-35-2

Formula:

C54H69N11O10S2

Molecular Weight:

1096.32

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.